Effects of Spiolto ® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects
Condition: Chronic Obstructive Pulmonary Disease Intervention: Drug: Olodaterol-Tiotropium Sponsors: Fraunhofer-Institute of Toxicology and Experimental Medicine; Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2020 Category: Research Source Type: clinical trials